Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Pfenex stock

Learn how to easily invest in Pfenex stock.

Pfenex is a biotechnology business based in the US. Pfenex shares (PFNX) are listed on the NYSE MKT and all prices are listed in US Dollars. Pfenex employs 88 staff and has a trailing 12-month revenue of around $41.1 million.

How to buy Pfenex stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – PFNX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award

eToro


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading

tastytrade


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Pfenex stock price (NYSE MKT: PFNX)

Use our graph to track the performance of PFNX stocks over time.

Pfenex shares at a glance

Information last updated 2020-11-01.
52-week range$0.00 - $0.00
50-day moving average $12.73
200-day moving average $9.09
Wall St. target price$13.00
PE ratio 268.6667
Dividend yield N/A (0%)
Earnings per share (TTM) $0.03

Buy Pfenex stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 7 of 7
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
eToro
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
tastytrade
Finder Rating: 4.1 / 5: ★★★★★
tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
$0
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Public.com
Finder Rating: 4 / 5: ★★★★★
Public.com
★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Robinhood
Finder Rating: 4.2 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Finder Rating: 4 / 5: ★★★★★
JPMorgan Self-Directed Investing
★★★★★
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
$0
Get $50 - $700
when you open and fund an account with $5,000 - $250,000+
Pay no commissions on stocks, ETFs, mutual funds and options.
Wealthfront
Finder Rating: 4 / 5: ★★★★★
Wealthfront
★★★★★
Stocks, ETFs
$500
N/A
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Pfenex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Pfenex stock undervalued or overvalued?

Valuing Pfenex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pfenex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Pfenex financials

Revenue TTM $41.1 million
Gross profit TTM $45.4 million
Return on assets TTM -4.95%
Return on equity TTM 0%
Profit margin -14.1%
Book value $2.16
Market Capitalization $437.3 million

TTM: trailing 12 months

Pfenex share dividends

We're not expecting Pfenex to pay a dividend over the next 12 months.

Pfenex share price volatility

Over the last 12 months, Pfenex's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

PFNX.US volatility(beta: 1.32)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Pfenex's is 1.3233. This would suggest that Pfenex's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Pfenex overview

Pfenex Inc. , a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis. The company also develops PF743, a recombinant crisantaspase; PF745, a recombinant crisantaspase with half-life extension technology; and PF810, a peptide based next generation therapeutic which is in preclinical development, as well as offers sparX-1 (PF753) and sparX-2 (PF754). In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.

Frequently asked questions

What percentage of Pfenex is owned by insiders or institutions?
Currently 0.423% of Pfenex shares are held by insiders and 82.431% by institutions.
How many people work for Pfenex?
Latest data suggests 88 work at Pfenex.
When does the fiscal year end for Pfenex?
Pfenex's fiscal year ends in December.
Where is Pfenex based?
Pfenex's address is: 10790 Roselle Street, San Diego, CA, United States, 92121
What is Pfenex's ISIN number?
Pfenex's international securities identification number is: US7170711045
What is Pfenex's CUSIP number?
Pfenex's Committee on Uniform Securities Identification Procedures number is: 717071104

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site